{"id":"https://openalex.org/W2952068838","doi":"https://doi.org/10.1016/j.jvacx.2019.100030","title":"Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch\u2122 in rhesus macaques: An exploratory, pre-clinical feasibility assessment","display_name":"Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch\u2122 in rhesus macaques: An exploratory, pre-clinical feasibility assessment","publication_year":2019,"publication_date":"2019-06-20","ids":{"openalex":"https://openalex.org/W2952068838","doi":"https://doi.org/10.1016/j.jvacx.2019.100030","mag":"2952068838","pmid":"https://pubmed.ncbi.nlm.nih.gov/31384745","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6668242"},"language":"en","primary_location":{"id":"doi:10.1016/j.jvacx.2019.100030","doi":"https://doi.org/10.1016/j.jvacx.2019.100030","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jvacx.2019.100030","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2590136219300312/pdf","source":{"id":"https://openalex.org/S4210231534","display_name":"Vaccine X","issn_l":"2590-1362","issn":["2590-1362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine: X","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S2590136219300312/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057080815","display_name":"Brian K. Meyer","orcid":"https://orcid.org/0000-0001-8854-4528","observed_orcids":["https://orcid.org/0000-0001-8854-4528"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Brian K. Meyer","raw_affiliation_strings":["New Technologies, Vaccine Drug Product Development, Vaccine Process Research and Development, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Technologies, Vaccine Drug Product Development, Vaccine Process Research and Development, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038629041","display_name":"Mark A.F. Kendall","orcid":"https://orcid.org/0000-0003-2885-4473","observed_orcids":["https://orcid.org/0000-0003-2885-4473"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210153216","display_name":"Vaxxas (Australia)","ror":"https://ror.org/05x3zk779","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153216"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mark A.F. Kendall","raw_affiliation_strings":["Delivery of Drugs and Genes Group (DG), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland QLD 4072, Australia","Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Delivery of Drugs and Genes Group (DG), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland QLD 4072, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I4210153216"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Donna M. Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donna M. Williams","raw_affiliation_strings":["New Technologies, Vaccine Drug Product Development, Vaccine Process Research and Development, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Technologies, Vaccine Drug Product Development, Vaccine Process Research and Development, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111976151","display_name":"Andrew J. Bett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Bett","raw_affiliation_strings":["Infectious Disease and Vaccines, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease and Vaccines, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059368929","display_name":"Sheri A. Dubey","orcid":"https://orcid.org/0000-0002-0712-9865","observed_orcids":["https://orcid.org/0000-0002-0712-9865"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheri Dubey","raw_affiliation_strings":["Infectious Disease and Vaccines, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease and Vaccines, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088201063","display_name":"Renee C. Gentzel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renee C. Gentzel","raw_affiliation_strings":["Movement Disorders and Translation, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Movement Disorders and Translation, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109160825","display_name":"Danilo R. Casimiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danilo Casimiro","raw_affiliation_strings":["Infectious Disease and Vaccines, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease and Vaccines, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015270214","display_name":"Angus Harry Forster","orcid":"https://orcid.org/0000-0002-5363-2015","observed_orcids":["https://orcid.org/0000-0002-5363-2015"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I4210153216","display_name":"Vaxxas (Australia)","ror":"https://ror.org/05x3zk779","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153216"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Angus Forster","raw_affiliation_strings":["Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I4210153216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075181103","display_name":"Holly J. Corbett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Holly Corbett","raw_affiliation_strings":["Delivery of Drugs and Genes Group (DG), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland QLD 4072, Australia","Delivery of Drugs and Genes Group (D"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Delivery of Drugs and Genes Group (DG), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland QLD 4072, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Delivery of Drugs and Genes Group (D","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046952358","display_name":"Michael Lawrence Crichton","orcid":"https://orcid.org/0000-0002-3683-802X","observed_orcids":["https://orcid.org/0000-0002-3683-802X"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210153216","display_name":"Vaxxas (Australia)","ror":"https://ror.org/05x3zk779","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153216"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael Crichton","raw_affiliation_strings":["Delivery of Drugs and Genes Group (DG), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland QLD 4072, Australia","Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Delivery of Drugs and Genes Group (DG), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland QLD 4072, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I4210153216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044905669","display_name":"Ben Baker","orcid":"https://orcid.org/0000-0003-1561-3013","observed_orcids":["https://orcid.org/0000-0003-1561-3013"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210153216","display_name":"Vaxxas (Australia)","ror":"https://ror.org/05x3zk779","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153216"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"S. Ben Baker","raw_affiliation_strings":["Delivery of Drugs and Genes Group (DG), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland QLD 4072, Australia","Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Delivery of Drugs and Genes Group (DG), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland QLD 4072, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I4210153216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088601026","display_name":"Robert K. Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert K. Evans","raw_affiliation_strings":["New Technologies, Vaccine Drug Product Development, Vaccine Process Research and Development, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Technologies, Vaccine Drug Product Development, Vaccine Process Research and Development, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079522587","display_name":"Akhilesh Bhambhani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Akhilesh Bhambhani","raw_affiliation_strings":["New Technologies, Vaccine Drug Product Development, Vaccine Process Research and Development, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Technologies, Vaccine Drug Product Development, Vaccine Process Research and Development, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5057080815"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":2450,"currency":"USD","value_usd":2450},"apc_paid":{"value":2450,"currency":"USD","value_usd":2450},"fwci":1.656,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.79394888,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"2","issue":null,"first_page":"100030","last_page":"100030"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.8417999744415283,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.8417999744415283,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.10999999940395355,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14126","display_name":"Intramuscular injections and effects","score":0.04039999842643738,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/human-papillomavirus-vaccine","display_name":"HPV vaccine","score":0.9769999980926514},{"id":"https://openalex.org/keywords/9-valent-hpv-vaccine","display_name":"9-valent HPV vaccine","score":0.8330000042915344},{"id":"https://openalex.org/keywords/nanopatch","display_name":"Nanopatch","score":0.7760000228881836},{"id":"https://openalex.org/keywords/intradermal-vaccination","display_name":"intradermal vaccination","score":0.9409999847412109},{"id":"https://openalex.org/keywords/vaccine-immunogenicity","display_name":"vaccine immunogenicity","score":0.8029999732971191},{"id":"https://openalex.org/keywords/skin-delivery","display_name":"skin delivery","score":0.5379999876022339},{"id":"https://openalex.org/keywords/aluminium-adjuvants","display_name":"alum adjuvant","score":0.9409999847412109},{"id":"https://openalex.org/keywords/vaccine-dose","display_name":"vaccine dose","score":0.34700000286102295},{"id":"https://openalex.org/keywords/transfer-efficiency","display_name":"transfer efficiency","score":0.6430000066757202},{"id":"https://openalex.org/keywords/rhesus-macaques","display_name":"rhesus monkeys","score":0.8500000238418579},{"id":"https://openalex.org/keywords/reactogenicity","display_name":"reactogenicity","score":0.578000009059906},{"id":"https://openalex.org/keywords/nonhuman-primates","display_name":"non-human primates","score":0.7170000076293945}],"concepts":[{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.7176687717437744},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7171322107315063},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.6941162347793579},{"id":"https://openalex.org/C2777704310","wikidata":"https://www.wikidata.org/wiki/Q7300322","display_name":"Reactogenicity","level":4,"score":0.6367189288139343},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6018627882003784},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5102825164794922},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.46365484595298767},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.4514559209346771}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1016/j.jvacx.2019.100030","doi":"https://doi.org/10.1016/j.jvacx.2019.100030","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jvacx.2019.100030","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2590136219300312/pdf","source":{"id":"https://openalex.org/S4210231534","display_name":"Vaccine X","issn_l":"2590-1362","issn":["2590-1362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine: X","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5627634","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6668242","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6668242","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6668242","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine X","raw_type":"Text"},{"id":"pmid:31384745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31384745","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine: X","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:23362dc9fcfe434d85a9942b7889ce62","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/23362dc9fcfe434d85a9942b7889ce62","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vaccine: X, Vol 2, Iss , Pp - (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.jvacx.2019.100030","doi":"https://doi.org/10.1016/j.jvacx.2019.100030","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jvacx.2019.100030","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2590136219300312/pdf","source":{"id":"https://openalex.org/S4210231534","display_name":"Vaccine X","issn_l":"2590-1362","issn":["2590-1362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine: X","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"},{"id":"https://openalex.org/F4320310184","display_name":"Australian National Fabrication Facility","ror":"https://ror.org/04ypnrn45"},{"id":"https://openalex.org/F4320320431","display_name":"Australian National University","ror":"https://ror.org/019wvm592"},{"id":"https://openalex.org/F4320320984","display_name":"University of Queensland","ror":"https://ror.org/00rqy9422"},{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2952068838.pdf","grobid_xml":"https://content.openalex.org/works/W2952068838.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W200071826","https://openalex.org/W302614476","https://openalex.org/W1589844156","https://openalex.org/W1976076274","https://openalex.org/W1979919475","https://openalex.org/W1980654799","https://openalex.org/W1986481379","https://openalex.org/W1996585855","https://openalex.org/W2003909661","https://openalex.org/W2019961175","https://openalex.org/W2022065543","https://openalex.org/W2022163297","https://openalex.org/W2036937828","https://openalex.org/W2045172810","https://openalex.org/W2048317818","https://openalex.org/W2059316854","https://openalex.org/W2073192975","https://openalex.org/W2075192444","https://openalex.org/W2076432670","https://openalex.org/W2081027894","https://openalex.org/W2083707908","https://openalex.org/W2088368520","https://openalex.org/W2093692060","https://openalex.org/W2094028486","https://openalex.org/W2109757991","https://openalex.org/W2116058039","https://openalex.org/W2131018316","https://openalex.org/W2134552328","https://openalex.org/W2155451445","https://openalex.org/W2183596644","https://openalex.org/W2293145130","https://openalex.org/W2323467739","https://openalex.org/W2334749086","https://openalex.org/W2346565888","https://openalex.org/W2472221349","https://openalex.org/W2530241022","https://openalex.org/W2620739723","https://openalex.org/W2627084677","https://openalex.org/W2732601320","https://openalex.org/W2758166142","https://openalex.org/W2765559122","https://openalex.org/W2804983248","https://openalex.org/W2883601113","https://openalex.org/W2916890405","https://openalex.org/W6608204301"],"related_works":["https://openalex.org/W2073192975","https://openalex.org/W2164173266","https://openalex.org/W4404924893","https://openalex.org/W2054168699","https://openalex.org/W7106280428","https://openalex.org/W2593916983","https://openalex.org/W2102122199","https://openalex.org/W4296020612","https://openalex.org/W7160080234","https://openalex.org/W3128882982"],"abstract_inverted_index":{"The":[0,35,100,184,250],"human":[1],"papillomavirus":[2],"(HPV)":[3],"9-valent,":[4],"recombinant":[5,52],"vaccine":[6,30,54,65,293],"(Gardasil\u21229)":[7],"helps":[8],"protect":[9],"young":[10],"adults":[11],"(males":[12],"and":[13,18,168,172,222,264],"females)":[14],"against":[15],"anogenital":[16],"cancers":[17],"genital":[19],"warts":[20],"caused":[21],"by":[22,188],"certain":[23],"HPV":[24,53,78,137,152,215,243,255,296],"genotypes":[25],"(ref.":[26],"Gardasil\u21229":[27],"insert).":[28],"This":[29,279],"is":[31,281],"administered":[32],"intramuscularly":[33],"(IM).":[34],"aim":[36],"of":[37,77,108,147,213,240,276,285,295],"this":[38,135],"study":[39,97,251,280],"was":[40,116,161,179,196,206,233],"to":[41,129,198,237,266],"determine":[42],"preclinically":[43],"whether":[44],"intradermal":[45],"(ID)":[46],"vaccination":[47],"with":[48,68,81,122,150,176,218,260,272,291],"an":[49,229],"unadjuvanted":[50,151,214,254],"9-valent":[51],"using":[55,163,201],"a":[56,104,210,238,273,292],"first-generation":[57,220,262],"ID":[58,71,124],"delivery":[59,125,160],"device,":[60],"the":[61,69,95,118,130,144,148,169,177,202,219,261,267,282],"Nanopatch\u2122,":[62,145],"could":[63,257],"enhance":[64],"immunogenicity":[66],"compared":[67,236],"traditional":[70],"route":[72],"(Mantoux":[73],"technique).":[74],"IM":[75,246],"injection":[76],"VLPs":[79,138,153,165,216,244,256],"formulated":[80],"Merck":[82],"&":[83],"Co.,":[84],"Inc.,":[85],"Kenilworth,":[86],"NJ,":[87],"USA":[88],"Alum":[89],"Adjuvant":[90],"(MAA)":[91],"were":[92,141,154],"included":[93],"in":[94,181,228,247,269,288],"rhesus":[96,182,248],"for":[98],"comparison.":[99],"Nanopatch\u2122":[101,149,178,189,221,263],"prototype":[102],"contains":[103],"high-density":[105],"array":[106,121],"comprised":[107],"10,000":[109],"microprojections/cm2,":[110],"each":[111],"250":[112],"\u00b5m":[113],"long.":[114],"It":[115,205],"hypothesized":[117],"higher":[119],"density":[120],"shallower":[123],"may":[126],"be":[127,258],"superior":[128],"Mantoux":[131,203,225],"technique.":[132,204],"To":[133],"test":[134],"hypothesis,":[136],"without":[139],"adjuvant":[140],"coated":[142],"on":[143],"stability":[146],"evaluated":[155,180],"under":[156],"accelerated":[157],"conditions,":[158],"skin":[159,173,268],"verified":[162],"radiolabelled":[164],"or":[166,224],"FluoSpheres\u00ae,":[167],"immune":[170,185,230],"response":[171,186,231],"site":[174],"reaction":[175],"macaques.":[183,249],"induced":[187,200],"administration,":[190],"measured":[191],"as":[192],"HPV-specific":[193],"binding":[194],"antibodies,":[195],"similar":[197],"that":[199,209,232],"also":[207,252],"observed":[208],"lower":[211,235],"dose":[212],"delivered":[217,245,259],"applicator":[223,265],"technique":[226],"resulted":[227],"significantly":[234],"higher-dose":[239],"alum":[241],"adjuvanted":[242],"indicated":[253],"15":[270],"s":[271],"transfer":[274],"efficiency":[275],"approximately":[277],"20%.":[278],"first":[283],"demonstration":[284],"patch":[286],"administration":[287],"non-human":[289],"primates":[290],"composed":[294],"VLPs.":[297]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-06-27T00:00:00"}